Aspiriant 13F: New $994K Stake in DUHP

Aspiriant has taken a significant new stake in the DFA U.S. High Relative Profitability Portfolio (DUHP) ETF. In a filing on October 16, 2026, the firm disclosed that it acquired 23,712 shares, valued at approximately $993,770. This marks a notable entry for Aspiriant as it previously held no shares in the ETF.

What Changed in Aspiriant's Position

Aspiriant's new position in DUHP reflects a strategic move to invest in large U.S. companies with high profitability. The firm now holds 23,712 shares, which is a new buy and indicates growing interest in the ETF's investment strategy. This position adds to the increasing trend of institutional investors exploring options in high-relative profitability securities.

Other Institutional Activity in DUHP

On the same day, several other institutional investors also entered positions in DUHP. PFG Advisors acquired 111,297 shares valued at around $4.66 million, while DiNuzzo Private Wealth opened a new investment in the ETF. Additionally, Elser Financial Planning took a significant new position, showcasing the ETF's appeal among a variety of funds.

DFA U.S. High Relative Profitability Portfolio – ETF Class Shares Stock Down 1.0%

The shares of DUHP recently traded around $42.27, placing it just above its 200-day moving average. The stock is currently about 1.5% below its 52-week high of $42.90, indicating that it is performing well in the market but may have room for growth. Investors will be keeping an eye on how this position develops, especially with the recent inflow from multiple institutional investors.

Recent Earnings

There are no recent earnings data available for DUHP as of now, which may limit insights into its financial performance. Investors will want to watch for future earnings announcements to gauge the ETF's profitability.

Insider Buying and Selling at DFA U.S. High Relative Profitability Portfolio – ETF Class Shares

Insider activity can often provide additional insights into how company executives view the stock's future.

Analysts Set New Price Targets

There is no recent analyst coverage available for DUHP at this time. This section will be important once analysts begin issuing ratings and price targets, which can help shape market expectations.

About DUHP

The DFA U.S. High Relative Profitability Portfolio is designed to invest in a range of large U.S. companies that demonstrate high profitability compared to their peers. This strategy focuses on firms with robust earnings in relation to their book value or assets. With Aspiriant's new position, it seems that institutional interest in this ETF is growing, likely driven by its underlying investment philosophy.

Bottom Line

Aspiriant's new stake in DUHP reflects a broader trend of institutional investment in high-profitability securities. Observers should watch for how this position evolves, as well as any upcoming earnings reports from the ETF. Remember, 13F filings are backward-looking and may not fully represent the fund's current investment stance.